While Inspire Medical Systems Inc has underperformed by -4.14%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, INSP rose by 12.29%, with highs and lows ranging from $257.40 to $123.00, whereas the simple moving average jumped by 11.95% in the last 200 days.
On May 08, 2024, BofA Securities Downgraded Inspire Medical Systems Inc (NYSE: INSP) to Neutral. A report published by RBC Capital Mkts on April 19, 2024, Initiated its previous ‘Outperform’ rating for INSP. Morgan Stanley also rated INSP shares as ‘Overweight’, setting a target price of $250 on the company’s shares in an initiating report dated March 19, 2024. KeyBanc Capital Markets Initiated an Overweight rating on February 06, 2024, and assigned a price target of $278. Jefferies initiated its ‘Buy’ rating for INSP, as published in its report on January 19, 2024. Stifel’s report from January 02, 2024 suggests a price prediction of $210 for INSP shares, giving the stock a ‘Hold’ rating. Wells Fargo also rated the stock as ‘Equal Weight’.
Analysis of Inspire Medical Systems Inc (INSP)
Further, the quarter-over-quarter increase in sales is 29.65%, showing a positive trend in the upcoming months.
One of the most important indicators of Inspire Medical Systems Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of 1.03% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 8.35, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and INSP is recording 716.32K average volume. On a monthly basis, the volatility of the stock is set at 4.24%, whereas on a weekly basis, it is put at 4.57%, with a gain of 0.50% over the past seven days. Furthermore, long-term investors anticipate a median target price of $227.94, showing growth from the present price of $207.73, which can serve as yet another indication of whether INSP is worth investing in or should be passed over.
How Do You Analyze Inspire Medical Systems Inc Shares?
The Medical Devices market is dominated by Inspire Medical Systems Inc (INSP) based in the USA. When comparing Inspire Medical Systems Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 1143.26, there is a growth in quarterly earnings of 178.75%.
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 106.14% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
INSP shares are owned by institutional investors to the tune of 106.14% at present.
